Who we are
Blueprint Genetics is a genetic testing company focused on inherited diseases. With a patient-first mindset, we deliver high-quality genetic testing to the global clinical community across 15 medical specialties. Blueprint Genetics is based in Helsinki and Seattle, with a customer base spanning over 70 countries.
What we do
We provide high-quality genetic testing for a global clinical community. By combining a state-of-the-art laboratory process, the latest sequencing technology, AI empowered data-crunching tools and techniques, world-class professionals, and a holistic customer experience approach, we are bringing genetic knowledge to mainstream healthcare.
We provide clinicians and their patients with comprehensive and high-quality tools and resources for diagnosis of genetic conditions. In doing so, we provide possibilities for targeted treatment and individualized care for patients.
Are you the one?
Become part of something that makes a difference. Join our team and help us develop industry-changing solutions for the benefit of patients and families living with inherited diseases.
New study in pediatric epilepsy supports the value of early genetic testing as a tool for making an accurate and an early diagnosis in children
A study, recently published in PLOS ONE, evaluated the clinical utility and diagnostic yield of next-generation sequencing (NGS) based genetic testing in children who had their first unprovoked seizure between 2 and 5 years representing one of the first studies in this age group.Read more
See all news
The 24th Annual Meeting of the Irish Society of Human Genetics
Blueprint Genetics will be attending the 24th Annual Meeting of the Irish Society of Human Genetics The event brings together the clinical and research human genetics communities in Ireland, and provides an opportunity to present and discuss the latest updates associated with human genetics in Ireland. Access the virtual conference…
See all events